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Abstract
Background: Follicular dendritic cell sarcoma (FDCS) is a rare malignant neoplasm of follicular dendritic cells that
form a tight meshwork within lymphoid follicles. It occurs most commonly in the lymph nodes and occasionally at
extranodal sites, but rarely in the mediastinum. It is an under-recognized clinical entity without clear diagnosis. Due
to its rarity, FDCS is easily misdiagnosed by clinicians or pathologists.
Case Presentation: Herein, we report three unusual cases of mediastinal FDCS, including one with hyaline vascular
Castleman’s disease in woman. The clinicopathological characteristics and CT imagings were described. Their
diagnosis was confirmed by immunohistochemical stainings of specific markers. Their therapeutic intervention,
follow-up and outcomes were presented with brief literature review.
Conclusions: A huge mediastinal shallowly-lobulated, demarcated soft tissue mass, with speckled, strip-like, coarse
or arborizing calcification inside, and mild to moderate enhancement after contrast material administration on CT
image, should consider FDCS as a possible diagnosis.
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Background
Follicular dendritic cell sarcoma (FDCS) is a rare malig-
nancy arising from follicular dendritic cells which form an
arborizing meshwork within lymphoid follicles [1]. Since
Monda et al. first described the condition in 1986 [2],
FDCS has become gradually known as the lymphatic and
hematopoietic neoplasms based on the WHO classification
[3]. Approximately 200 cases of FDCS have been reported
in the English literatures so far. These lesions arise most
frequently in lymph nodes and occasionally at extranodal
sites, but rarely in the mediastinum [4]. Due to its uncom-
mon systemic symptoms, FDCS is difficult to be diagnosed.
Pathologically, FDCSs are well-circumscribed with spindle
to ovoid cells arranged in a fascicular, whorled or storiform
pattern. They typically present as a large mass with mean
diameter ranging from 7 to 10 cm [5]. To the best of our
knowledge, only three articles focused on the imaging fea-
tures of FDCS [6–8]. Immunohistochemistry is required to
confirm the diagnosis. FDCSs are usually positive for FDC
markers CD21, CD23, and CD35 [9]. Tumor cells also typ-
ically express vimentin, a soft tissue sarcoma marker [10].
The current study presents three case of mediastinal
FDCS and describes the pathological characteristics and
chest CT imagings. The diagnosis of FDCS in these
cases is confirmed by immunohistochemisty.
Case Presentation
Patient 1 was a 72-year-old woman. She complained about
chest tightness, dyspnea and trachyphonia for 3 months.
She had no fever, cough, expectoration or decompensation
during the course of disease, except increased serum ferritin
(663.6 μg/L). A contrast enhanced CT images of the chest
revealed a well-defined mass of homogeneous attenuation in
the superior middle mediastinum, and the mass measured
3.2 × 4.3 cm in diameter. An arborizing-pattern of coarse
calcification was seen within the lesion (Fig. 1). The mass
compressed adjacent trachea, esophagus and superior vena
cava. It had similar homogeneous enhancement as the adja-
cent great vessels on 18-Fluoro-deoxyglucose positron emis-
sion tomography (FDG PET)-CT images. Thoracoscopic
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biopsy was then performed. The oval and fusiform tumor
cells were slightly atypia with eosinophilic cytoplasm, and
large nuclei with obvious nucleoli and mitoses. Mixture of
lymphocytes and neutrophils patchily infiltrated among neo-
plastic cells. Immunohistochemical analysis showed that the
tumor cells were positive with CD21, CD23, CD35 and
HLA-DR, focal positive for CD20 and CD163. Patients re-
ceived radiotherapy alone without surgery, and died of the
disease due to metastasis one year after the diagnosis.
Patient 2 was a 51-year-old woman presented with a
history of chest tightness, chest pain, cough, expector-
ation and trachyphonia for 20 days. Serum ferritin was
elevated to 234.4 μg/L. A contrast enhanced chest CT
images revealed a well-defined 9.1 × 8.7 cm mass of
homogeneous attenuation in the right superior middle
mediastinum. A peripheral speckle-strip coarse calcifica-
tion was seen within the lesion (Fig. 2a,b). The mass was
excised and sectioned for histological examination. The
plump spindle tumor cells were diffusely proliferated
and densely arranged with significantly atypia, large nu-
clei and mitoses. Moreover, significant lymphocytic infil-
tration was noted. Immunohistochemical staining
showed positive expression of CD 21 and CD35 in
tumor cells. Patients underwent thoracic resection of the
tumor and received radiotherapy after the surgery. Pa-
tient died of the disease due to metastasis 10 months
after the diagnosis.
Patient 3 was a 53-year-old woman who was admitted
for a mediastinal mass found during annual physical
examination. An unenhanced chest CT scan revealed a
mass of 10.3 × 7.6 cm in the anterior mediastinum,
with well-demarcated shallowly-lobulated soft tissue
protruding to the left lung around several nodules
(Fig. 3a). The entity was excised for histological
examination. The tissue sections showed an intact
capsule and fleshy pinkish white surface, bordering
with the pericardium and bilateral mediastinal pleura,
and several nodules around as well. Microscopically,
the spindle tumor cells were in fascicular, swirling or
diffusely irregular arrangement mixed with lympho-
cyte infiltration. Tumor cell nuclei were round, oval
or fusiform, vacuolated with granular chromatin
(Fig. 3b). Partial areas showed histological features
characteristic of hyaline vascular Castleman’s disease.
Moreover, the tumor cells were positive for CD21
(Fig. 3c) and CD35. The pathological diagnosis was
mediastinal FDCS and hyaline vascular Castleman’s
disease. Patient underwent surgical resection of the
tumor without radiotherapy. Patient is still alive one
and half years after surgery.
CT imaging protocol
The Definition As CT scanner was utilized for Case 1,
whereas the Siemens Sensation 16 CT scanner was
applied for both Case 2 and 3. The single phase
scanning method was used for the enhanced scan.
Non-ionic contrast agent (iohexol or ioversol) of 90–
Fig. 1 Axial contrast-enhanced CT image of the chest shows a
well-defined lobulated homogeneous soft tissue mass in the
superior middle mediastinum with peripheral speckle calcification
and mild enhancement
Fig. 2 a Axial and (b) coronal contrast-enhanced CT images show a huge well-delineated shallowly-lobulated heterogeneously enhanced soft tissue
mass in the right superior middle mediastinum with irregular hypodense areas of necrosis and multiple speckle-strip calcifications
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100 mL was injected at a rate of 2.8–3.0 mL/s.
Enhanced scan began 38 s after the injection of the
contrast agent. The scan was performed with a
thickness of 7 mm, a spacing of 7 mm, and a pitch
of 1.0. Images were reconstructed with thickness of
2 mm.
Discussion
According to the WHO classification of lymphatic and
hematopoietic neoplasms, FDCS is grouped as the
histiocytic and dendritic cell neoplasm [3]. FDCS equally
affects males and females, with a median age of 47 years
at diagnosis, widely ranged from 14 to 77 years [11]. The
patients usually present with enlarged lymph nodes or a
painless mass with a gradually increase in size. Systemic
manifestations are rare. More than half of the lesions
were located in lymph nodes, often involved in cervical
and axillary nodes. Other cases were found in extranodal
sites, including tonsils, spleen, oral cavity, parotid glands,
gastrointestinal tract, liver, soft tissue, skin and even
breast [12, 13].
The etiology and pathogenesis of FDCS have not been
thoroughly clarified. Approximate 1/3 of cases in the
literature were associated with Castleman’s disease,
usually the hyaline vascular type, which may occur
concomitantly or thereafter. Patients receiving long-term
treatment are prone to develop this neoplasm [12].
Several pathologic features of FDCS have been
described. The tumor cells usually are round, oval or
spindle, with eosinophilic or amphophilic cytoplasm,
small nucleoli, granular or vacuole chromatin, and
mitosis. Focal storiform arrangement may be seen. The
tumor cells are commonly interspersed with lympho-
cytes showing typically prominent perivascular cuffing.
The tumor cells are typically positive for FDCS specific
markers, such as CD21and CD35 [12,14]. Some also
positively expressed Vimentin, S-100 and CD68 [15].
Similar to the previous reports, the tumor cells in
this study are spindle, fascicular, swirl or diffusely
arrangedwith lymphocyte infiltration. The tumor cells
have fusiform and vacuolated nuclei with granular
chromatin. The immunostaining results show positive
expression of FDCS molecular markers, such as
CD21 and CD35.
FDCS is extremely rare and scarcely reported in the
radiological literature, which brought difficulty in making
accurate diagnosis before operation or biopsy. According
to our cases and those in the literature, mediastinal FDCSs
locate in the anterior (see case 3), middle (see case 1
and 2) or posterior mediastinum [6,8], and are usually
Fig. 3 a Axial unenhanced CT image shows a well-demarcated shallowly-lobulated soft tissue mass in the anterior mediastinum, protruding to the left
lung with several nodules around. b Photomicrograph (original magnification, ×200; hematoxylin-eosin stain) shows the oval and fusiform tumor cells,
admixed with lymphocytes and neutrophils. c Photomicrograph shows CD-21 immunostaining positive tumor cells
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well-demarcated, slightly lobulated soft tissue masses
sized from 3 cm to 10 cm (mean 6.7 cm). Necrosis
and hemorrhage are uncommon, although areas of
necrosis may be seen in huge tumors (see case 2).
Peripheral calcifications are found in some cases,
which are speckled, strip-like, coarse or arborizing.
FDCS typically shows mild to moderate enhancement
after contrast material administration. PET-CT and
MRI may provide help to improve the diagnosis of
the disease.
Mediastinal FDCS are different from Castleman’s disease,
lymphoma and metastasis. Hyaline vascular Castleman
disease classically shows much more intense contrast
enhancement than FDCS. Calcification rarely occurs in
untreated lymphoma or metastasis. A huge mediastinal
mass with clear margin, internal coarse or arborizing
calcifications, and relatively little necrosis or hemorrhage,
favors imaging diagnosis of FDCS rather than other
mediastinal tumors [6].
Conclusions
A huge mediastinal shallowly-lobulated, demarcated soft
tissue mass, with speckled, strip-like, coarse or arboriz-
ing calcification inside, and mild to moderate enhance-
ment after contrast material administration on CT
image, should consider FDCS as a possible diagnosis.
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